| News
ti&m opens branch in Basel
16.06.2022
ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is counting on a strong economic and financial location and the large catchment area for the job market.

Group picture of the employees of ti&m (img: ti&m)
ti&m has chosen Basel as the location for its new branch. According to a press release, the company hopes to “even more closely serve” its existing clients located in north-western Switzerland with banks, insurance, health insurance funds, and retail as well as asset management companies, hospitals, and energy companies. Furthermore, ti&m plans to gain additional new customers from the life science and medtech industries from its new location. Settlement has been supported by Basel Area Business & Innovation.
Head Basel at ti&m Gabriel Salm commented: “Basel is a strong financial and economic location of national importance with many innovative companies from various industries, organizations, and public institutes.” He adds that “a new, interesting job market is emerging: at the center of the north-west of Switzerland, Basel has a large catchment area and is also attractive to workers from Alsace and southern Germany.”
50 to 70 employees in three years
The company relies on young, highly qualified IT specialists from the University of Basel and the University of Applied Sciences Northwestern Switzerland as well as the Baden-Wuerttemberg Cooperative State University in Lörrach and the École nationale supérieure d’ingénieurs Sud-Alsace in Mülhausen. “Our aim is to reach 50 to 70 employees in three years’ time.”
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read More